We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.98B
AUM Growth
-$105M
Cap. Flow
-$183M
Cap. Flow %
-6.16%
Top 10 Hldgs %
31.09%
Holding
494
New
47
Increased
58
Reduced
153
Closed
91

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$53.7M
2
META icon
Meta Platforms (Facebook)
META
+$43.3M
3
HON icon
Honeywell
HON
+$35M
4
ROP icon
Roper Technologies
ROP
+$32.4M
5
ZBRA icon
Zebra Technologies
ZBRA
+$29.4M

Top Sells

Rank Stock Value
1
ANET icon
Arista Networks
ANET
+$59M
2
BA icon
Boeing
BA
+$52.8M
3
FFIV icon
F5
FFIV
+$42.9M
4
NTAP icon
NetApp
NTAP
+$40.4M
5
PANW icon
Palo Alto Networks
PANW
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 31.69%
2 Healthcare 14.72%
3 Consumer Discretionary 13.84%
4 Communication Services 10.89%
5 Financials 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZUMZ icon
251
Zumiez
ZUMZ
$330M
$79K ﹤0.01%
3,020
– –
SCL icon
252
Stepan Co
SCL
$1.47B
$77K ﹤0.01%
840
-3,230
-79% -$288K
ACAD icon
253
Acadia Pharmaceuticals
ACAD
$5.06B
$76K ﹤0.01%
2,840
– –
EGRX
254
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$76K ﹤0.01%
1,372
– –
LGND icon
255
Ligand Pharmaceuticals
LGND
$5.89B
$72K ﹤0.01%
1,010
– –
EBS icon
256
Emergent Biosolutions
EBS
$229M
$71K ﹤0.01%
1,470
-220
-13% -$10.5K
NX icon
257
Quanex
NX
$967M
$69K ﹤0.01%
+3,650
New +$61.2K
ARNA
258
DELISTED
Arena Pharmaceuticals Inc
ARNA
$69K ﹤0.01%
1,170
– –
HALO icon
259
Halozyme
HALO
$11.6B
$68K ﹤0.01%
3,980
– –
PTCT icon
260
PTC Therapeutics
PTCT
$6.23B
$66K ﹤0.01%
1,460
– –
CEO
261
DELISTED
CNOOC Limited
CEO
$66K ﹤0.01%
390
– –
C icon
262
Citigroup
C
$227B
$65K ﹤0.01%
930
-20
-2% -$1.34K
FOLD
263
DELISTED
Amicus Therapeutics
FOLD
$62K ﹤0.01%
4,960
– –
PBR icon
264
Petrobras
PBR
$118B
$62K ﹤0.01%
3,987
-30
-0.7% -$457
WFC icon
265
Wells Fargo
WFC
$265B
$61K ﹤0.01%
1,290
+50
+4% +$2.34K
E icon
266
ENI
E
$79.4B
$60K ﹤0.01%
1,810
-10
-0.5% -$330
INSM icon
267
Insmed
INSM
$29.4B
$59K ﹤0.01%
2,310
– –
IMMU
268
DELISTED
Immunomedics Inc
IMMU
$54K ﹤0.01%
3,870
– –
PTLA
269
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$54K ﹤0.01%
1,990
– –
BF
270
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
$54K ﹤0.01%
2,970
-10
-0.3% -$182
SHOE
271
Shoe Station Group
SHOE
$437M
$53K ﹤0.01%
3,860
– –
PETS icon
272
PetMed Express
PETS
$42.1M
$52K ﹤0.01%
3,310
– –
RUTH
273
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$52K ﹤0.01%
2,278
– –
MYGN icon
274
Myriad Genetics
MYGN
$311M
$50K ﹤0.01%
1,790
– –
ICPT
275
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$50K ﹤0.01%
630
– –
9 10
11
12 13

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Smith Group Asset Management held 494 positions worth $2.98B, down 3.4% from $3.09B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Smith Group Asset Management withdrew a net $183M in Q2 2019, closing 91 positions and reducing 153 holdings. Its most notable exit was F5, an estimated $42.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Oracle worth $56.5M.

  • Smith Group Asset Management's largest Q2 2019 buy was Oracle: 992,560 shares worth $56.5M.
  • Smith Group Asset Management added most to Meta Platforms (Facebook) in Q2 2019, an estimated $43.3M increase.
  • Smith Group Asset Management's biggest Q2 2019 reduction was Arista Networks, cutting an estimated $59M.
  • Smith Group Asset Management fully exited F5 in Q2 2019, selling an estimated $42.9M.
  • Smith Group Asset Management's ten largest holdings make up 31% of its $2.98B portfolio in Q2 2019.
  • Smith Group Asset Management opened 47 new positions and closed 91 in Q2 2019.
  • Smith Group Asset Management's portfolio value fell 3.4% quarter-over-quarter to $2.98B.

Based on Smith Group Asset Management's 13F filing for Q2 2019, filed 8 Aug 2019.